Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance

Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Microbiol
Principais autores:	Wilson, K. E., Cassiday, P. K., Popovic, T., Sanden, G. N.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Bacteriology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120648/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12149356/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.8.2942-2944.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!